ATP Citrate Lyase Inhibitors as Novel Cancer Therapeutic Agents

E-ISSN： 2212-3970|7|2|154-167

ISSN： 1574-8928

Source： Recent Patents on Anti-Cancer Drug Discovery, Vol.7, Iss.2, 2012-05, pp. : 154-167

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic and therapeutic implications of increased ATP citrate lyase expression in human epithelial ovarian cancer

Oncology Reports, Vol. 27, Iss. 4, 2012-01 ,pp. : 1156-1162

Spandidos Publications

Access to resources Recommend Favorite

Small-Molecule Inhibitors of Bcl-2 Family Proteins as Therapeutic Agents in Cancer

Recent Patents on Anti-Cancer Drug Discovery, Vol. 3, Iss. 1, 2008-01 ,pp. : 20-30

Bentham Science Publishers

Access to resources Recommend Favorite

Argininosuccinate lyase is a potential therapeutic target in breast cancer

Oncology Reports, Vol. 34, Iss. 6, 2015-01 ,pp. : 3131-3139

Spandidos Publications

Access to resources Recommend Favorite

Novel Therapeutic Agents Against Cancer Stem Cells of Chronic Myeloid Leukemia

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 10, Iss. 2, 2010-02 ,pp. : 111-115

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Patents Therapeutic Agents for Cancer

Recent Patents on Anti-Cancer Drug Discovery, Vol. 1, Iss. 2, 2006-06 ,pp. : 255-284

Bentham Science Publishers

Access to resources Recommend Favorite